Clinical Trial

Atrial Fibrillation in Beta-Thalassemia

Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-08-18; most recent amendment 2026-02-21.
Status change: Not Yet Recruiting → Recruiting 2022-09-12
Trial Details
NCT Number NCT05508932
Lead Sponsor University Hospital of Ferrara
Conditions Atrial Fibrillation, Thalassemia
Enrollment 350 participants
Start Date 2022-09-01
Primary Completion 2032-06-01 (estimated)
Study Completion 2032-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-24